A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit

Source
The journal of antimicrobial chemotherapy - ISSN 0305-7453-81:4 (2026) p. 1-14
Author(s)
    Sarah Hendrickx, Kayhan Ilbeigi, Eli S.J. Thore, Michael G. Bertram, Estefania Calvo-Alvarez, Sener Cintesun, Ana Isabel Olias-Molero, Maria Jesus Corral, Marta Mateo-Barrientos, Jerome Estaquier, Sebastien Pomel, Jose Maria Alunda, Sheraz Gul, Katrien Van Bocxlaer, Frederic Frezard, Joana Tavares, Anabela Cordeiro Da Silva, Maria Paola Costi, Louis Maes, Guy Caljon

Isolation and characterization of antiplasmodial and antimicrobial compounds from Tetracera alnifolia using a bioassay-guided approach

Source
RSC advances - ISSN 2046-2069-16:12 (2026) p. 10635-10647
Author(s)

Development of methods for species-specific quantitation of Eimeria oocysts in mixed vaccines for chickens and turkeys

Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Biomedical Sciences, 2026,229 p.
Author(s)

Discovery and development of an advanced lead for the treatment of African trypanosomiasis

Source
ACS Infectious Diseases - ISSN 2373-8227-11:1 (2024) p. 131-143
Author(s)

In vivo bioluminescence imaging reveals differences in Leishmania infantum parasite killing kinetics by antileishmanial reference drugs

Source
ACS Infectious Diseases - ISSN 2373-8227-10:6 (2024) p. 2101-2107
Author(s)